Binaxnow Covid-19 Ag Card

Drug Details

The BinaxNOW COVID-19 Ag Card is a rapid antigen test designed to detect active COVID-19 infections by identifying specific proteins from the SARS-CoV-2 virus in nasal swab samples. This test delivers results in approximately 15 minutes, making it a convenient option for quick diagnosis. It is authorized for use in individuals aged 15 and older, and for children as young as 2 years old when an adult collects the sample. The test can be used for both symptomatic and asymptomatic individuals. Each kit includes all necessary components: a test card, nasal swab, and reagent solution. The process involves collecting a nasal swab sample, applying it to the test card, and waiting for the result to appear. A positive result is indicated by two pink or purple lines, while a negative result shows only one line. The BinaxNOW test has received Emergency Use Authorization from the FDA and is intended for use by medical professionals or trained operators proficient in performing rapid lateral flow tests. It is important to note that while the test offers quick results, negative outcomes should be considered presumptive and, if necessary, confirmed with a molecular assay for patient management decisions.